Literature DB >> 24506637

A matter of collection and detection for intraoperative and noninvasive near-infrared fluorescence molecular imaging: to see or not to see?

Banghe Zhu1, John C Rasmussen1, Eva M Sevick-Muraca1.   

Abstract

PURPOSE: Although fluorescence molecular imaging is rapidly evolving as a new combinational drug/device technology platform for molecularly guided surgery and noninvasive imaging, there remains no performance standards for efficient translation of "first-in-humans" fluorescent imaging agents using these devices.
METHODS: The authors employed a stable, solid phantom designed to exaggerate the confounding effects of tissue light scattering and to mimic low concentrations (nM-pM) of near-infrared fluorescent dyes expected clinically for molecular imaging in order to evaluate and compare the commonly used charge coupled device (CCD) camera systems employed in preclinical studies and in human investigational studies.
RESULTS: The results show that intensified CCD systems offer greater contrast with larger signal-to-noise ratios in comparison to their unintensified CCD systems operated at clinically reasonable, subsecond acquisition times.
CONCLUSIONS: Camera imaging performance could impact the success of future "first-in-humans" near-infrared fluorescence imaging agent studies.

Entities:  

Mesh:

Year:  2014        PMID: 24506637      PMCID: PMC3987664          DOI: 10.1118/1.4862514

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  20 in total

1.  Delivery of gamma-imaging agents by liposomes.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1999-04-05       Impact factor: 15.470

2.  Fluorescence-enhanced optical imaging in large tissue volumes using a gain-modulated ICCD camera.

Authors:  Anuradha Godavarty; Margaret J Eppstein; Chaoyang Zhang; Sangeeta Theru; Alan B Thompson; Michael Gurfinkel; Eva M Sevick-Muraca
Journal:  Phys Med Biol       Date:  2003-06-21       Impact factor: 3.609

3.  Reduction of excitation light leakage to improve near-infrared fluorescence imaging for tissue surface and deep tissue imaging.

Authors:  Banghe Zhu; John C Rasmussen; Yujie Lu; Eva M Sevick-Muraca
Journal:  Med Phys       Date:  2010-11       Impact factor: 4.071

Review 4.  The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery.

Authors:  Boudewijn E Schaafsma; J Sven D Mieog; Merlijn Hutteman; Joost R van der Vorst; Peter J K Kuppen; Clemens W G M Löwik; John V Frangioni; Cornelis J H van de Velde; Alexander L Vahrmeijer
Journal:  J Surg Oncol       Date:  2011-04-14       Impact factor: 3.454

5.  Preclinical studies on tumor-specific fluorescent targeting agents: the need for a gold standard of tumor localization.

Authors:  Stijn Keereweer; Pieter B A A Van Driel; Clemens W G M Lowik
Journal:  Mol Imaging Biol       Date:  2014-02       Impact factor: 3.488

6.  Validating the sensitivity and performance of near-infrared fluorescence imaging and tomography devices using a novel solid phantom and measurement approach.

Authors:  B Zhu; I-C Tan; J C Rasmussen; E M Sevick-Muraca
Journal:  Technol Cancer Res Treat       Date:  2012-02

7.  Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results.

Authors:  Gooitzen M van Dam; George Themelis; Lucia M A Crane; Niels J Harlaar; Rick G Pleijhuis; Wendy Kelder; Athanasios Sarantopoulos; Johannes S de Jong; Henriette J G Arts; Ate G J van der Zee; Joost Bart; Philip S Low; Vasilis Ntziachristos
Journal:  Nat Med       Date:  2011-09-18       Impact factor: 53.440

8.  Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and technetium-99m methoxyisobutylisonitrile scintimammography in the detection of breast tumours.

Authors:  H Palmedo; H Bender; F Grünwald; P Mallmann; P Zamora; D Krebs; H J Biersack
Journal:  Eur J Nucl Med       Date:  1997-09

9.  Use of panitumumab-IRDye800 to image cutaneous head and neck cancer in mice.

Authors:  C Hope Heath; Nicholas L Deep; Lauren N Beck; Kristine E Day; Larissa Sweeny; Kurt R Zinn; Conway C Huang; Eben L Rosenthal
Journal:  Otolaryngol Head Neck Surg       Date:  2013-03-22       Impact factor: 3.497

10.  Real-time in vivo molecular detection of primary tumors and metastases with ratiometric activatable cell-penetrating peptides.

Authors:  Elamprakash N Savariar; Csilla N Felsen; Nadia Nashi; Tao Jiang; Lesley G Ellies; Paul Steinbach; Roger Y Tsien; Quyen T Nguyen
Journal:  Cancer Res       Date:  2012-11-27       Impact factor: 12.701

View more
  17 in total

1.  Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention.

Authors:  Brian W Pogue; Keith D Paulsen; Kimberley S Samkoe; Jonathan T Elliott; Tayyaba Hasan; Theresa V Strong; Daniel R Draney; Joachim Feldwisch
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

2.  Optimization of fluorescent imaging in the operating room through pulsed acquisition and gating to ambient background cycling.

Authors:  Kristian J Sexton; Yan Zhao; Scott C Davis; Shudong Jiang; Brian W Pogue
Journal:  Biomed Opt Express       Date:  2017-04-26       Impact factor: 3.732

3.  Setting Standards for Reporting and Quantification in Fluorescence-Guided Surgery.

Authors:  Charlotte Hoogstins; Jan Jaap Burggraaf; Marjory Koller; Henricus Handgraaf; Leonora Boogerd; Gooitzen van Dam; Alexander Vahrmeijer; Jacobus Burggraaf
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

4.  Toward nodal staging of axillary lymph node basins through intradermal administration of fluorescent imaging agents.

Authors:  Funda Meric-Bernstam; John C Rasmussen; Savitri Krishnamurthy; I-Chih Tan; Banghe Zhu; Jamie L Wagner; Gildy V Babiera; Elizabeth A Mittendorf; Eva M Sevick-Muraca
Journal:  Biomed Opt Express       Date:  2013-12-13       Impact factor: 3.732

Review 5.  Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging.

Authors:  Alisha V DSouza; Huiyun Lin; Eric R Henderson; Kimberley S Samkoe; Brian W Pogue
Journal:  J Biomed Opt       Date:  2016-08-01       Impact factor: 3.170

6.  Deglycosylation of mAb by EndoS for improved molecular imaging.

Authors:  Peng Gao; Kenneth L Pinkston; Nathaniel Wilganowski; Holly Robinson; Ali Azhdarinia; Banghe Zhu; Eva M Sevick-Muraca; Barrett R Harvey
Journal:  Mol Imaging Biol       Date:  2015-04       Impact factor: 3.488

Review 7.  A review of performance of near-infrared fluorescence imaging devices used in clinical studies.

Authors:  B Zhu; E M Sevick-Muraca
Journal:  Br J Radiol       Date:  2015-01       Impact factor: 3.039

8.  Longitudinal far red gene-reporter imaging of cancer metastasis in preclinical models: a tool for accelerating drug discovery.

Authors:  Banghe Zhu; Holly Robinson; Songlin Zhang; Grace Wu; Eva M Sevick-Muraca
Journal:  Biomed Opt Express       Date:  2015-08-13       Impact factor: 3.732

Review 9.  Emerging lymphatic imaging technologies for mouse and man.

Authors:  Eva M Sevick-Muraca; Sunkuk Kwon; John C Rasmussen
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

10.  Determining the Performance of Fluorescence Molecular Imaging Devices Using Traceable Working Standards With SI Units of Radiance.

Authors:  Banghe Zhu; John C Rasmussen; Maritoni Litorja; Eva M Sevick-Muraca
Journal:  IEEE Trans Med Imaging       Date:  2015-11-03       Impact factor: 10.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.